---
input_text: 'Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure. Curative
  therapies for sickle cell disease (SCD) include allogeneic human leukocyte antigen
  (HLA)- matched sibling and haploidentical hematopoietic cell transplant (HCT), gene
  therapy, and gene editing. However, comparative trial data that might facilitate
  selecting one curative therapy over another are unavailable. New strategies to decrease
  graft rejection and graft-versus-host disease (GVHD) risks are needed to expand
  haploidentical HCT. Myeloablative gene therapy and gene editing also has limitations.
  Herein, we review recent studies on curative therapies for SCD in the past 5 years.'
raw_completion_output: |-
  primary_disease: Sickle Cell Disease (SCD)

  medical_actions: Allogeneic human leukocyte antigen (HLA)-matched sibling hematopoietic cell transplant; Haploidentical hematopoietic cell transplant; Gene therapy; Gene editing; Strategies to decrease graft rejection; Strategies to decrease graft-versus-host disease (GVHD); Myeloablative gene therapy

  symptoms: Graft rejection; Graft-versus-host disease (GVHD)

  chemicals: 

  action_annotation_relationships: Allogeneic human leukocyte antigen (HLA)-matched sibling hematopoietic cell transplant TREATS Sickle Cell Disease (SCD); Haploidentical hematopoietic cell transplant TREATS Sickle Cell Disease (SCD); Gene therapy TREATS Sickle Cell Disease (SCD); Gene editing TREATS Sickle Cell Disease (SCD); Strategies to decrease graft rejection PREVENTS Graft rejection IN Sickle Cell Disease (SCD); Strategies to decrease graft-versus-host disease (GVHD) PREVENTS Graft-versus-host disease (GVHD) IN Sickle Cell Disease (SCD); Myeloablative gene therapy TREATS Sickle Cell Disease (SCD)
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Myeloablative gene therapy TREATS Sickle Cell Disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - Allogeneic human leukocyte antigen (HLA)-matched sibling hematopoietic cell
      transplant
    - Haploidentical hematopoietic cell transplant
    - MAXO:0001001
    - Gene editing
    - Strategies to decrease graft rejection
    - Strategies to decrease graft-versus-host disease (GVHD)
    - Myeloablative gene therapy
  symptoms:
    - Graft rejection
    - Graft-versus-host disease (GVHD)
  action_annotation_relationships:
    - subject: <Allogeneic human leukocyte antigen (HLA)-matched sibling hematopoietic
        cell transplant>
      predicate: <TREATS>
      object: HP:0007760
      qualifier: <>
      subject_qualifier: <Allogeneic, HLA-matched, sibling>
      object_qualifier: <>
      subject_extension: <hematopoietic cell transplant>
      object_extension: <>
    - subject: Haploidentical hematopoietic cell transplant
      predicate: TREATS
      object: HP:0007760
    - subject: MAXO:0001001
      predicate: TREATS
      object: HP:0007760
    - subject: Gene editing
      predicate: TREATS
      object: HP:0007760
    - subject: Strategies to decrease graft rejection
      predicate: PREVENTS
      object: Graft rejection
      qualifier: MONDO:0007374
    - subject: Strategies to decrease graft-versus-host disease
      predicate: PREVENTS
      object: Graft-versus-host disease (GVHD)
      qualifier: MONDO:0007374
    - subject: Myeloablative gene therapy
      predicate: TREATS
      object: HP:0007760
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:35341
    label: steroids
  - id: CHEBI:81579
    label: erythropoietin
  - id: MAXO:0001017
    label: Vaccination
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000747
    label: Allogeneic hematopoietic stem cell transplantation (HSCT)
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:35480
    label: analgesics
  - id: CHEBI:33281
    label: antibiotics
  - id: MAXO:0001077
    label: Splenectomy
  - id: MAXO:0000756
    label: Blood transfusion
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: HP:0001297
    label: Stroke
  - id: HP:0002863
    label: Myelodysplastic syndrome
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:82594
    label: Ferritin
  - id: MONDO:0000984
    label: thalassemia
  - id: MONDO:0018881
    label: myelodysplastic syndrome
  - id: HP:0002140
    label: Ischemic Stroke
  - id: MONDO:0005380
    label: avascular necrosis
  - id: MAXO:0009047
    label: total hip replacement
  - id: HP:0010885
    label: avascular necrosis
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:41879
    label: dexamethasone
  - id: CHEBI:9570
    label: thiotepa
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:9168
    label: sirolimus
  - id: CHEBI:8764
    label: mycophenolate mofetil
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000515
    label: Extracorporeal life support
  - id: HP:0001708
    label: Right ventricular failure
  - id: HP:0033515
    label: opioid dependence
  - id: MONDO:0005632
    label: Acute chest syndrome in sickle cell disease
  - id: HP:0001945
    label: fever
  - id: HP:0001878
    label: Hemolytic anemia
  - id: CHEBI:6121
    label: ketamine
  - id: CHEBI:17303
    label: morphine
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0031274
    label: hypovolemic shock
  - id: MAXO:0000110
    label: Vitamin D supplementation
  - id: HP:0100512
    label: Vitamin D deficiency
  - id: CHEBI:27300
    label: Vitamin D
  - id: CHEBI:28940
    label: Cholecalciferol
